Skip to main content
. 2024 Mar 8;22:252. doi: 10.1186/s12967-024-05061-6

Table 1.

The baseline characteristics of study participants

Variables Overall Without albuminuria With albuminuria P value
Sample, n (%) 6739 5161(76.58) 1578(23.42)
Age, years 56.52 ± 0.29 55.39 ± 0.33 61.15 ± 0.49  < 0.001
BMI, kg/m2 32.22 ± 0.14 32.11 ± 0.15 32.67 ± 0.32 0.109
Gender, n (%) 0.999
 Female 3181(47.20) 2469(47.36) 712(47.37)
 Male 3558(52.80) 2692(52.64) 866(52.63)
Race/Ethnicity, n (%)  < 0.001
 Mexican Americans 1185(17.58) 882(8.86) 303(11.28)
 Non-Hispanic Black 1408(20.89) 1046(10.28) 362(13.47)
 Non-Hispanic White 2719(40.35) 2120(68.14) 599(61.79)
 Other races 1427(21.18) 1113(12.73) 314(13.46)
Education, n (%)  < 0.001
 Less Than 9th Grade 1004(14.90) 710(6.96) 294(12.17)
 9–11th Grade 1064(15.79) 785(11.64) 279(14.47)
 High School 1575(23.37) 1214(24.48) 361(26.46)
 Some College 1880(27.90) 1471(32.19) 409(28.40)
 College or above 1216(18.04) 981(24.73) 235(18.50)
Marital status, n (%) 0.002
 Married 3760(55.79) 2936(60.22) 824(55.54)
 Unmarried 704(10.45) 562(10.85) 142(9.47)
 Others 2275(33.76) 1663(28.93) 612(34.99)
PIR, n (%)  < 0.001
  ≤ 1.30 2335(34.65) 1711(21.33) 624(30.30)
 1.30–3.50 2620(38.88) 1965(36.64) 655(40.43)
  > 3.50 1784(26.47) 1485(42.03) 299(29.27)
Serum creatinine, μmol/L 82.19 ± 0.58 78.48 ± 0.39 97.36 ± 2.59  < 0.001
Serum uric acid, μmol/L 344.40 ± 1.55 341.27 ± 1.73 357.21 ± 3.21  < 0.001
Hypertension, n (%) 5036(74.73) 3659(69.39) 1377(86.84)  < 0.001
Hyperlipidemia, n (%) 5742(85.21) 4353(85.11) 1389(88.27) 0.031
Smoke, n (%) 0.011
 Never 3434(50.95) 2694(51.25) 740(44.91)
 Former 2140(31.76) 1590(32.32) 550(37.76)
 Current 1165(17.29) 877(16.43) 288(17.33)
CVD, n (%) 1348(20.00) 868(15.65) 480(27.91)  < 0.001
Alcohol status, n (%)  < 0.001
 Never 1816(26.95) 1434(30.56) 382(25.44)
 Former 1510(22.41) 1076(17.22) 434(24.84)
 Mild 2264(33.60) 1793(39.23) 471(33.54)
 Heavy 1816(26.95) 1434(30.56) 382(25.44)
Medication use, n (%)
 Anti-hypertensive drugs 822(12.20) 618(11.48) 204(12.28) 0.508
 Anti-diabetic drugs 2844(42.20) 1937(34.31) 907(54.61)  < 0.001
Total PA: achieved, n (%) 3365(49.93) 2705(55.99) 660(42.84)  < 0.001
OPA: achieved, n (%) 1941(28.80) 1555(34.26) 386(27.25) 0.003
TPA: achieved, n (%) 730(10.83) 568(9.69) 162(8.27) 0.167
LTPA: achieved, n (%) 1600(23.74) 1329(28.73) 271(18.05)  < 0.001

Continuous variables were presented as mean ± SE, and categorical variables were presented as the frequency with percentage

BMI, body mass index; PIR, poverty income ratio; CVD, cardiovascular disease; PA, physical activity; OPA, occupation-related PA; TPA, transportation-related PA; LTPA, leisure-time PA; SE, standard error